Semaglutide has transformed obesity and diabetes care, offering significant weight loss and glucose control with once-weekly dosing. Here’s a look at its clinical promise and expanding role in medicine.
Disease Biology
Eli Lilly’s once-weekly insulin, efsitora alfa, has shown promising results in Phase 3 clinical trials. The innovative treatment demonstrated A1C reductions comparable to daily basal insulins, with a consistent safety profile.
In addition, the research showed an 80% reduction in the hospitalization risk of cardiovascular disease in individuals with Type 1 diabetes who did not have a previous history of such illnesses.
Many Americans suffer from long-term inflammatory skin disorders that have no known etiology and frequently no effective treatments other than symptom control. A recent study may open the door to personalized treatment and diagnostic tests based on precision medicine. Their findings were published in the journal Scientific Reports. We isolated […]
According to the study, even in the absence of established triggers for these antibodies, such as blood thinners (heparin) or previous vaccinations.
A biotech startup that was spun off from UC San Diego uses deep learning to screen for potential antibiotic candidates as a TB outbreak spreads in Kansas.
The production of energy that powers cells and facilitates their operation depends on mitochondria. On the other hand, disorders like type 2 diabetes are linked to mitochondrial abnormalities. Individuals with this condition are unable to use the insulin their pancreas produces to maintain normal blood sugar levels or create enough […]
Research into the genomes of malaria parasites opens the door to more potent, novel therapies.
Here the investigators infected mice with SARS-CoV-2 and sequenced the genomes of viruses replicating in the brain versus the lung. In the lung, spike protein had a very close structure to the infecting virus.
New findings out of Emory University are shaking theories of the origin of Alzheimer’s the leading cause of dementia among older adults worldwide.
